CTOs on the Move

Sentinelle Medical Inc

www.sentinellemedical.com

 
Sentinelle Medical Inc is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

BTG International

BTG is a global healthcare company focused on Interventional Medicine. Our innovative medical technology helps physicians treat their patients through minimally invasive procedures. Today we have a growing portfolio of products that advance the treatment of cancer, vascular conditions and severe emphysema. Our Pharmaceuticals business provides products that help patients overexposed to certain medications or toxins. Our mission is to provide imaginative new ways to treat disease; making a real difference for patients, and a valuable contribution to healthcare. As medicine moves from major surgery to minor procedure, no company endeavours to do more to help doctors in their quest to see more, reach further and treat smarter. We understand their needs and equip them with tools and techniques that would have seemed like science fiction only a generation ago. We invest in clinical evidence that helps demonstrate the value of our treatments to patients, doctors, and healthcare systems. With relentless curiosity we`ll work with clinicians to find elegant new ways to extend our power over disease and transform patient care. There are no limits to where our ideas will take us.

PTS Inc

PTS Inc is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MedPro Systems

MedPro Systems is a Mount Arlington, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vasomedical, Inc.

Vasomedical, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Westbury, NY. To find more information about Vasomedical, Inc., please visit www.vasomedical.com

NeoChord

NeoChord is a venture backed medical device company that has developed a proprietary device which allows mitral valve repair to be performed on a beating heart through a 2- to 3-inch incision between the ribs in patients with severe mitral valve regurgitation (MR). In contrast, most mitral valve repair procedures are performed through a 3 to 10 inch chest incision (sternotomy) that involves cutting through the sternum, opening the rib cage, stopping the heart and placing the patient on cardio-pulmonary bypass (CPB).